Relationship between Expression of β-tubulin-Ⅲ Plus Stathmin in Advanced Non-Small Cell Lung Cancer and its Sensitivity to Venorelbine Chemotherapy
| Autor: | Xiaolin PU, Jun WANG, Lin XU, Junqing MA, Zhilu WANG, Fuyin LIU, Min YANG, Weifei FAN, Lijuan MENG |
|---|---|
| Jazyk: | čínština |
| Rok vydání: | 2009 |
| Předmět: | |
| Zdroj: | Chinese Journal of Lung Cancer, Vol 12, Iss 1, Pp 49-53 (2009) |
| Druh dokumentu: | article |
| ISSN: | 1009-3419 1999-6187 |
| Popis: | Background and objective Vinorelbine plus cisplatin/carboplatin (NP) is one of the standard combination chemotherapy regimen for advanced non-small cell lung cancer (NSCLC). The aim of this study is toinvestigate the relationship between expression of Stathmin and β-tubulin-Ⅲ in NSCLC biopsies and sensitivity to Vinorelbine, which would provide a basis of the proper medicine choice for the patients' tailored chemotherapy. Methods Western blot was used to investigate the expression of Stathmin and β-tubulin-Ⅲ protein in the biopsies from stage ⅢB-Ⅳ NSCLC patients. All the cases were divided into 4 groups according to the level of the two proteins, of which L represented both protein expressed lowly, B showed β-tubulin-Ⅲ lowly expressed group, while S showed Stathmin lowly, and H represented both protein highly expressed. At the same time, all the patients accepted NP chemotherapy for 2 or 4 cycles according to the responses to this regimen. The responses rate (RR), media survival time (MST), time to progress (TTP) were observed. Results A total of 90 stage ⅢB-Ⅳ NSCLC patients were divided into 4 groups, 22 in L group, 23 in B and S group while 22 in H group respectively. The RR of the groups were 68.2%, 26.1%, 30.4% and 22.7% respectively.There were statistically significant differences between L group and other 3 groups (P |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|